Key Market Indicator:
Ad-hoc news is mandatory information from listed companies that must be made available to investors. Depending on the occasion and content of the news, it can have an impact on the share price. The newsfeed covers a wide range of topics relevant to investor relations and is recommended as an important source of information before making an investment decision.
Fri, 17.04.2026
Semperit AG Holding
Semperit AG Holding: Operating result in Q1 expected to be higher than the previous year; full-year earnings forecast remains unchanged
Vienna, April 17, 2026 – As part of the preparation of Semperit AG Holding’s interim report for the first quarter of 2026, it is becoming apparent that EBITDA for the first quarter of 2026 will be higher than i [ … ]
Thu, 16.04.2026
Drägerwerk AG & Co. KGaA
Ad-hoc notification in accordance with Sec. 17 of the MAR
Drägerwerk AG & Co. KGaA: Preliminary figures Q1 2026: Earnings significantly above prior year
Lübeck, April 16, 2026 – Following a decline in the same period of the prior year, Dräger’s net sales rose by 6.9 percent (net of currency effects; nominal: 3.5 percent) in the first quarter [ … ]
Thu, 16.04.2026
United Labels AG
Ad hoc announcement by United Labels AG dated April 16, 2026ISIN: DE 0005489561, WKN: 548956, Ticker: ULC
United Labels AG: Postponement of the Publication of Financial Reports for the 2025 Fiscal Year
Muenster, April 16, 2026. United Labels AG (ISIN: DE 0005489561, WKN: 548956) hereby announces that the publication of the financial reports [ … ]
Thu, 16.04.2026
Circus SE
Circus to Acquire Belgian Food Robotics Company Alberts
Munich, 16 April 2026 – Circus SE (ISIN: DE000A2YN355 / XETRA: CA1) has signed a binding agreement for the acquisition of the Belgian food robotics company Alberts, a European provider and market-leading pioneer in autonomous food production systems.
Founded in 2015, the company has developed [ … ]
Thu, 16.04.2026
BioVersys AG
Ad hoc announcement pursuant to Art. 53 LR
Basel, Switzerland. April 16, 2026, 7am CEST
BV100 is a potential best-in-class anti-infective agent in treating hospital-acquired bacterial pneumonia (HABP) or ventilator-associated bacterial pneumonia (VABP) caused by carbapenem-resistant Acinetobacter baumannii (CRAB).
The RIV-TARGET Phas [ … ]
Thu, 16.04.2026
VAT Group AG
“Ad hoc announcement pursuant to Art. 53 LR”
Very strong first quarter order intake on high customer demand; revenue recognition temporarily delayed following middle east conflict
High demand for leading-edge semiconductor manufacturing equipment is driving strong order momentum for VAT; book to bill ratio of 1.6x achieved as order backlog contin [ … ]
Wed, 15.04.2026
AIXTRON SE
THIS ANNOUNCEMENT, INCLUDING THE INFORMATION INCLUDED HEREIN, IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, WHETHER WHOLLY OR IN PART, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH, OR TO PERSONS IN ANY JURISDICTION TO WHOM, SUCH RELEAS [ … ]
Wed, 15.04.2026
Gerresheimer AG
Gerresheimer AG: Creditors agree to extend the due date for submitting the audited 2025 annual and consolidated financial statements
Duesseldorf, April 15, 2026. Gerresheimer AG (ISIN: DE000A0LD6E6, "Gerresheimer") has reached an agreement with its creditors regarding an extension of the due date for submitting the audited 2025 annual and consolid [ … ]
Wed, 15.04.2026
Formycon AG
Disclosure of inside information pursuant to Article 17 of Regulation (EU) No 596/2014
Formycon AG announces improved preliminary figures for the 2025 fiscal year and sets date for the publication of the annual financial statements
Group EBITDA of approx. € -4 million (vs. € -12 million) and adjusted EBITDA of approx. € -2 million (vs. € -7 milli [ … ]
Wed, 15.04.2026
FamiCord AG
FamiCord AG publishes preliminary figures for 2025 and outlook for 2026
Leipzig, 15 April 2026 – FamiCord AG closed the year 2025 with an overall consistently solid operational development and continued its path of increasing efficiency. This is the conclusion reached by the Management Board on the basis of the preliminary business figures availab [ … ]
